Neuronetics (STIM) Revenue (2017 - 2026)

Neuronetics (STIM) has 10 years of Revenue data on file, last reported at $34.5 million in Q1 2026.

• Quarterly Revenue rose 7.75% year-over-year to $34.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $151.6 million (up 69.52% YoY) and the FY2025 annual result came in at $149.2 million, up 99.17% from the prior year.
• Revenue retreated to $34.5 million in Q1 2026 per STIM's latest filing, from $41.8 million in the prior quarter.
• Across five years, Revenue topped out at $41.8 million in Q4 2025 and bottomed at $14.2 million in Q1 2022.
• The 5-year median for Revenue is $18.2 million (2022), against an average of $23.2 million.
• The widest annual swing landed in 2024, when Revenue declined 6.59%; it then surged 131.66% in 2025.
• Tracing STIM's Revenue over 5 years: stood at $18.2 million in 2022, then advanced by 11.63% to $20.3 million in 2023, then grew by 10.73% to $22.5 million in 2024, then soared by 85.73% to $41.8 million in 2025, then retreated by 17.53% to $34.5 million in 2026.
• Per Business Quant, the three latest STIM Revenue figures stand at $34.5 million (Q1 2026), $41.8 million (Q4 2025), and $37.3 million (Q3 2025).

Peer Comparison